Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL2182 Target Snapshot

5-hydroxytryptamine receptor 1E · SINGLE PROTEIN · Homo sapiens

833Compounds
147Assays
7Approved Drugs
335.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt P28566. Use UniProt P28566 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P28566 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats 5-hydroxytryptamine receptor 1E as ChEMBL target CHEMBL2182, mapped to UniProt P28566. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
5-hydroxytryptamine receptor 1E
SINGLE PROTEIN · Homo sapiens
As of 2026-09-14
ChEMBL target ID
CHEMBL2182
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
P28566
5-hydroxytryptamine receptor 1E
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether 5-hydroxytryptamine receptor 1E is the right protein anchor across sources, using UniProt P28566 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein Label5-hydroxytryptamine receptor 1E
UniProt AccessionP28566
Component TypeProtein
Sequence Length365 aa

5-hydroxytryptamine receptor 1E

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as 5-hydroxytryptamine receptor 1E, mapped to UniProt P28566. Sequence length is 365 aa.

Mapped IDP28566
Review name5-hydroxytryptamine receptor 1E
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

7
Approved
2
Phase III
3
Phase II
Assay Mix

Activity Type Distribution

IC5045.0
KI290.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL39 8.4 Ki 4.0 Clinical
CHEMBL432713 8.2 Ki 6.31 Preclinical
CHEMBL65547 7.36 Ki 44.0 Clinical
CHEMBL263881 7.03 Ki 93.0 Clinical
CHEMBL22744 7.0 IC50 99.0 Preclinical
CHEMBL3039520 6.9 Ki 126.87 Approved
CHEMBL138989 6.85 Ki 140.0 Preclinical
CHEMBL5091373 6.75 Ki 180.0 Preclinical
CHEMBL137781 6.7 Ki 200.0 Preclinical
CHEMBL343755 6.55 Ki 280.0 Preclinical
Distribution

pChEMBL Value Distribution

28
5.0
30
5.5
25
6.0
6
6.5
4
7.0
2
7.5
2
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Approved Drugs

Approved Drugs

LASMIDITAN
CHEMBL3039520
Approved 2020
BREXPIPRAZOLE
CHEMBL2105760
Approved 2015
FROVATRIPTAN SUCCINATE
CHEMBL2138684
Approved 2001
CLOZAPINE
CHEMBL42
Approved 1989
DIHYDROERGOTAMINE MESYLATE
CHEMBL1200517
Approved 1946
Assay Landscape

Assay Landscape

147
Total Assays
77
Tested Compounds
3
Assay Types
Binding — 142 assays, 77 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 106 52 6.0
cell-based format 34 22 5.7
assay format 2 3 6.9
Functional — 3 assays, 18 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 3 18 5.2
ADME — 2 assays, 0 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 2 0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine